- Advertise
- Contact Us
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
© 2022 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
American Heart Association
Concomitant Tricuspid Repair Could Lower Mortality Risk in Patients with Degenerative Mitral Regurgitation
November 26, 2021
A recent trial found concomitant tricuspid annuloplasty could lower the risk of mortality and progression to severe tricuspid regurgitation among patients with degenerative mitral valve regurgitation.
Digital Monitoring Programs Can Aid in Reaching Blood Pressure, Cholesterol Goals
November 19, 2021
The latest data from the digital care transformation program provides insight into effects of digital monitoring programs on helping patients achieve blood pressure and cholesterol goals.
AHA 2021: Top Data Slideshow
November 17, 2021
Every year, AHA Scientific Sessions provides clinicians and researchers with a glimpse into the latest data from clinical trials. Our editorial staff's top picks for late-breaking data from AHA 2021 Scientific Sessions includes AVATAR, RAPID CABG, REVERSE-IT, and more.
Low-Dose Aspirin Not Linked to Increased Dementia Risk in Patients with Diabetes
November 16, 2021
The ASCEND trial indicates low-dose aspirin use was associated with a nonsignificant reduction in risk of dementia among patients with diabetes and no history of cardiovascular disease.
Optimal Prescription of SGLT2 Inhibitors in Hospitalized HFrEF Patients Could Provide Substantial Benefit
November 15, 2021
The most recent analysis from TRANSLATE-HF suggests optimal prescription of dapagliflozin, based on the FDA label, could reduce the risk of mortality and readmission among patients hospitalized for HFrEF.
AHA Study Assesses Risk of Pericarditis and Myocarditis Associated with COVID-19 Vaccines
November 15, 2021
A study from the Intermountain Heart Institute details the risk of pericarditis and myocarditis associated with COVID-19 vaccines among patients from within their institution's health system.
Fitbit Heart Study Provides Further Backing for Wearables in Detecting AFib
November 15, 2021
Data from the Fitbit Heart study presented at AHA 2021 suggest a novel algorithm for detecting irregular heart rhythms had a positive predictive value of 98% for detecting atrial fibrillation in patients with undiagnosed atrial fibrillation.
LDL-C Above 160 mg/dL Associated with Increased MACE Risk in Younger Patients
November 15, 2021
Viet Le, PA-C, discusses the results of a study he led from AHA 2021 examining 10-year risk of MACE among patients with an LDL-C from 160-189 mg/dL compared to those with an LDL-C below 160 mg/dL.
REVERSE-IT: Bentracimab Shows Promise as Fast-Acting Ticagrelor Reversal Agent
November 15, 2021
Deepak Bhatt, MD, MPH, discusses the results of the interim analysis of the REVERSE-IT trial presented at AHA 2021, which indicates bentracimab provided immediate and sustained reversal of ticagrelor's antiplatelet effects in patients requiring urgent surgery or experiencing major bleeding.
Dabigatran and Warfarin Provide Similar Effect on Cognitive Function in AFib
November 15, 2021
After 2 years, there was little difference in cognitive function between patients with nonvalvular atrial fibrillation receiving dabigatran or warfarin in the GIRAF trial, which was presented at AHA 2021.